Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis

Caley, L.R. orcid.org/0000-0001-8957-1018, Gillgrass, L., Zagoya, C. et al. (5 more authors) (2025) Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. Journal of Cystic Fibrosis, 24 (4). pp. 787-791. ISSN: 1569-1993

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: Elexacaftor/tezacaftor/ivacaftor (ETI) therapy; Cystic fibrosis, Gastrointestinal symptoms, CFAbd-Score, abdominal
Dates:
  • Accepted: 11 January 2025
  • Published (online): 14 January 2025
  • Published: July 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Molecular Medicine
The University of Leeds > Faculty of Biological Sciences (Leeds) > Faculty of Biological Sciences Office (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 30 Jan 2025 15:18
Last Modified: 20 Aug 2025 14:20
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.jcf.2025.01.010
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics